Clinical Trials Logo

Filter by:
NCT ID: NCT00687778 Recruiting - Lung Cancer Clinical Trials

11C-Acetate PET/CT Non-FDG-Avid Tumors

Start date: May 2008
Phase: N/A
Study type: Observational

F18-FDG is the widely used PET tracer in the routine practice of oncologic disease imaging using the technology of PET-CT. However, FDG-avidity is a characteristic of the individual tumor. There are various types of human malignancies, which are not taking FDG in access. In these cases FDG is not a sensitive tracer of imaging. In search for other tumor PET tracers, C11-Acetate has been shown recently in a few early studies to have a potential value in imaging of non-FDG-avid tumors. The purpose of the current study is to assess the role of 11C-acetate PET in various tumors, which often are not detected by 18F-FDG and were not widely assessed until now.

NCT ID: NCT00687427 Not yet recruiting - Hand Injury Clinical Trials

Return to Work After Hand Injury: the Role of Medical, Demographic and Psycho-Social Factors

Start date: June 2008
Phase: N/A
Study type: Observational

The purpose of this study is to investigate the extent of return to work (RTW) after traumatic hand injury and to identify factors that are related to RTW.

NCT ID: NCT00686309 Not yet recruiting - Asthma Clinical Trials

Comparison of On-line and Off-line Measurements of Exhaled Nitric Oxide (NO)

Start date: July 2010
Phase: N/A
Study type: Observational

Asthma is a major health problem worldwide. The measurement of fractional exhaled nitric oxide (FENO) has been established as a valuable non invasive and simple tool in the diagnosis of asthma and may also act as a useful surrogate inflammatory marker on which to base treatment decisions in asthma management algorithms. The measurement is useful also in other respiratory diseases. Current methods of measuring FENO include on line measurements by heavy duty expensive analyzers which are not widely and easily available. Off line measurements of breath samples which can be analysed later may be a simple solution. We hypothesize tha toff line measurements of NO will be as reliable and valid as those measured on-line

NCT ID: NCT00686075 Completed - Healthy Clinical Trials

A Study to Evaluate the Safety, Tolerability, Immunogenicity and Vaccine-like Viral Shedding of MEDI-534, Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3), in Healthy 6 to <24 Month-old Children and in 2 Month-old Infants

Start date: June 2008
Phase: Phase 1/Phase 2
Study type: Interventional

Primary objective of this study is to describe the safety and tolerability of multiple doses of MEDI-534 in children 6 to less than (<) 24 months of age and in infants 2 months of age.

NCT ID: NCT00686023 Not yet recruiting - Femur Fracture Clinical Trials

Comparing Surgical Techniques for CRIF of Pertrochanteric Fractures

Start date: June 2008
Phase: N/A
Study type: Interventional

Hypothesis: Inflatable intra medullary femoral nailing is superior to DHS in terms of blood loss, operative complications and postoperative rehabilitation in the management of pertrochanteric femur neck fractures.

NCT ID: NCT00685321 Recruiting - Schizophrenia Clinical Trials

Tolerability, Safety and Efficacy of the H1-coil Deep Transcranial Magnetic Stimulation in Subjects With Negative Symptoms and Cognitive Deficits of Schizophrenia

Start date: June 2008
Phase: N/A
Study type: Interventional

Objectives:The purpose of the study is to explore the efficacy and safety of H1-Coil deep brain rTMS in subjects with negative symptoms and cognitive deficits of schizophrenia (deficit syndrome), currently treated with atypical antipsychotics. Patient Population: The intention is to treat 45 patients diagnosed with schizophrenia, who are currently suffering mainly from negative symptoms and cognitive deficits (deficit syndrome). The patients will be of all racial, ethnic and gender categories, ranging from 18 to 65 years of age, and have PANSS negative≥21 and PANSS positive<24. Patients will be recruited from both academic and private research centers. Structure: The study is a randomized, prospective, 8 weeks, double blind study. Blinding: The treatment administrator and the study personnel and patients will be masked to the treatment being administrated. Concurrent Control: The study group will receive active rTMS treatment and the control group will receive an inactive, sham treatment.

NCT ID: NCT00685282 Completed - Infertility Clinical Trials

The Effect of Stress on DNA Integrity and the Effect of Cognitive Behavioral Therapy on Stress and Infertility in Women

Start date: November 2008
Phase: N/A
Study type: Interventional

The general hypothesis of the research is that stress decreases fertility and that Cognitive Behavioral Therapy will reduce stress and increase fertility. Secondarily, we hypothesize that stress has a detrimental effect on DNA integrity and that stress reduction will reduce DNA damage in the cell.

NCT ID: NCT00684970 Recruiting - Clinical trials for Metastatic Castration Resistant Prostate Cancer (CRPC)

Phase IIB Clinical Trial of Hamsa-1™ in Metastatic Castration Resistant Prostate Cancer (CRPC)

TLH-202
Start date: March 2009
Phase: Phase 2
Study type: Interventional

Hamsa-1™ is an anti-angiogenic drug combination designed for the treatment of cancer. The investigational product Hamsa-1™ comprises of four well-known active components. The therapy is administrated at a unique dosing regimen that was found to be effective and advantageous in terms of safety.The product is formulated as an oral suspension, conveniently administrated by the patients at home and not requiring medical staff assistance. This Phase IIb clinical trial aims to evaluate the efficacy of Hamsa-1™ for the treatment of metastatic Castration Resistant Prostate Cancer (CRPC) patients.

NCT ID: NCT00684606 Recruiting - Pregnancy Clinical Trials

Transcervical Foley Catheter With or Without Oxytocin for Induction of Labor

Start date: May 2008
Phase: N/A
Study type: Interventional

The purpose of the present study is to evaluate the possible benefit of concurrent IV Oxytocin infusion with trans cervical Foley catheter for pre-induction cervical ripening.

NCT ID: NCT00684528 Recruiting - Diabetes Type 2 Clinical Trials

A Double-Blind, Randomized, Active-Comparator (Metformin) Controlled, Clinical Trial to Study the Efficacy and Safety of the Strategy to Start Patients With Type 2 Diabetes Mellitus on Janumet™ Compared to Metformin

Start date: June 2008
Phase: Phase 3
Study type: Interventional

Comparison between the effectiveness of one anti-diabetic drug (Metformin, To combination of this drug and additional drug (Janufer), In the community setting.